Harvard's Global Clinical Science Program
A new video highlights the Clinical Science Scholars Program hosted by Semmelweis University for Harvard students. The initiative offers undergraduates a structured opportunity for international research and clinical shadowing. Such global experiences are often considered standouts on medical school applications.
This nine-month clinical research program, which launched in 2023, is structured as a postgraduate certificate course. The hybrid curriculum is anchored by three intensive workshops: one at Semmelweis University in Budapest, one held virtually, and a final workshop at Harvard Medical School in Boston. The core curriculum is divided into five distinct modules covering epidemiology, biostatistics, research ethics, clinical trials, and leadership skills. This academic foundation is supplemented by over 85 recorded online lectures and monthly webinars, ensuring continuous engagement. A key component of the program is a capstone project where each scholar develops a detailed research proposal with mentorship from both Harvard and Semmelweis faculty. The top ten proposals are presented in a webinar, and the top three are showcased during the final workshop in Boston, offering significant visibility. The partner institution, Semmelweis University, is Hungary's oldest medical university, founded in 1769. It is highly ranked globally, placing in the 251-300 bracket in the Times Higher Education World University Rankings and specifically in the 151-200 range for clinical medicine. For pre-meds, such in-depth research experience is a significant differentiator. Data from the Association of American Medical Colleges shows that over 90% of students matriculating into top-20, research-focused medical schools have substantial research experience on their applications. The program aims to equip participants with practical skills to design and conduct clinical trials, analyze data, and write successful grant proposals. These competencies are directly applicable to a future in academic medicine and demonstrate a high level of commitment to the field. Initially running from 2023 to 2026 with approximately 220 students, the program will continue under a new funding model through the 2028/2029 academic year. The collaboration was designed to build a critical mass of researchers in Central and Eastern Europe with high-level postgraduate training.
